These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 17240209)
1. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. Follet H; Li J; Phipps RJ; Hui S; Condon K; Burr DB Bone; 2007 Apr; 40(4):1172-7. PubMed ID: 17240209 [TBL] [Abstract][Full Text] [Related]
2. Effect of short-term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats. Barrett JG; Sample SJ; McCarthy J; Kalscheur VL; Muir P; Prokuski L J Orthop Res; 2007 Aug; 25(8):1070-7. PubMed ID: 17444501 [TBL] [Abstract][Full Text] [Related]
3. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Allen MR; Iwata K; Phipps R; Burr DB Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660 [TBL] [Abstract][Full Text] [Related]
4. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats. Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014 [TBL] [Abstract][Full Text] [Related]
5. Response of the osteocyte syncytium adjacent to and distant from linear microcracks during adaptation to cyclic fatigue loading. Colopy SA; Benz-Dean J; Barrett JG; Sample SJ; Lu Y; Danova NA; Kalscheur VL; Vanderby R; Markel MD; Muir P Bone; 2004 Oct; 35(4):881-91. PubMed ID: 15454095 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading. Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619 [TBL] [Abstract][Full Text] [Related]
7. Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen. Zaman G; Jessop HL; Muzylak M; De Souza RL; Pitsillides AA; Price JS; Lanyon LL J Bone Miner Res; 2006 Aug; 21(8):1297-306. PubMed ID: 16869728 [TBL] [Abstract][Full Text] [Related]
8. Effect of fatigue loading and associated matrix microdamage on bone blood flow and interstitial fluid flow. Muir P; Sample SJ; Barrett JG; McCarthy J; Vanderby R; Markel MD; Prokuski LJ; Kalscheur VL Bone; 2007 Apr; 40(4):948-56. PubMed ID: 17234467 [TBL] [Abstract][Full Text] [Related]
9. Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts. Nishiguchi T; Akiyoshi T; Anami S; Nakabayashi T; Matsuyama K; Matzno S J Pharm Pharmacol; 2009 Jun; 61(6):781-8. PubMed ID: 19505369 [TBL] [Abstract][Full Text] [Related]
10. Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women. Qiu S; Phipps RJ; Ebetino FH; Palnitkar S; Sudhaker Rao D Calcif Tissue Int; 2010 Nov; 87(5):392-7. PubMed ID: 20809096 [TBL] [Abstract][Full Text] [Related]
11. Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate. Allen MR; Turek JJ; Phipps RJ; Burr DB Bone; 2011 Jul; 49(1):128-32. PubMed ID: 20637914 [TBL] [Abstract][Full Text] [Related]
12. Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate. Kanatsu K; Aihara E; Okayama M; Kato S; Takeuchi K J Gastroenterol Hepatol; 2004 May; 19(5):512-20. PubMed ID: 15086594 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate treatment delays stress fracture remodeling in the rat ulna. Kidd LJ; Cowling NR; Wu AC; Kelly WL; Forwood MR J Orthop Res; 2011 Dec; 29(12):1827-33. PubMed ID: 21598308 [TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis. Brennan O; Kennedy OD; Lee TC; Rackard SM; O'Brien FJ J Orthop Res; 2011 Mar; 29(3):419-24. PubMed ID: 20886644 [TBL] [Abstract][Full Text] [Related]
15. The role of estrogen in the control of rat osteocyte apoptosis. Tomkinson A; Gevers EF; Wit JM; Reeve J; Noble BS J Bone Miner Res; 1998 Aug; 13(8):1243-50. PubMed ID: 9718192 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450 [TBL] [Abstract][Full Text] [Related]
17. Bone adaptation to a mechanical loading program significantly increases skeletal fatigue resistance. Warden SJ; Hurst JA; Sanders MS; Turner CH; Burr DB; Li J J Bone Miner Res; 2005 May; 20(5):809-16. PubMed ID: 15824854 [TBL] [Abstract][Full Text] [Related]
18. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats. Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352 [TBL] [Abstract][Full Text] [Related]
19. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs. Mashiba T; Hui S; Turner CH; Mori S; Johnston CC; Burr DB Calcif Tissue Int; 2005 Sep; 77(3):180-5. PubMed ID: 16265598 [TBL] [Abstract][Full Text] [Related]
20. In vivo fatigue loading of the rat ulna induces both bone formation and resorption and leads to time-related changes in bone mechanical properties and density. Hsieh YF; Silva MJ J Orthop Res; 2002 Jul; 20(4):764-71. PubMed ID: 12168665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]